PRA023 IMPROVED HEALTH-RELATED QUALITY OF LIFE AS MEASURED BY IBDQ-32 IN A PHASE 2 TRIAL FROM PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Laurent Peyrin-Biroulet  ¹     Bruce E. Sands  ²     Silvio Danese  ³     David T. Rubin  ⁴     Deanna Nguyen  ⁵     Quinn Dinh  ⁵     Alina Melnyk  ⁵     Bin Dong  ⁵     Christopher Ma  ⁶     Timothy Ritter  ⁷     Remo Panaccione  ^8    
1 Last Inserm U954 and CHU de Nancy, Lorraine University, Nancy, France
² Icahn School of Medicine at Mount Sinai, New York, United States
³ Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milano, Italy
⁴ University of Chicago Medicine, Chicago, United States
⁵ Prometheus Biosciences, Inc., San Diego, United States
⁶ University of Calgary, Departments of Medicine and Community Health Sciences, Calgary, Canada
⁷ GI Alliance, Southlake, United States
⁸ University of Calgary, Calgary, Canada

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)